Phase II study of meloxicam with carboplatin plus docetaxel in first-line treatment of patients with advanced non-small cell lung cancer (NSCLC)

被引：0
|
作者：
Ishida, T.
Kanazawa, K.
Oizumi, H.
Yokouchi, H.
Yamazaki, K.
Akie, K.
Sukoh, N.
Harada, M.
Munakata, M.
Isobe, H.
机构：
[1] Fukushima Med Univ, Fukushima, Japan
[2] Hokkaido Univ, Sapporo, Hokkaido, Japan
[3] Sapporo City Gen Hosp, Sapporo, Hokkaido, Japan
[4] Hokkaido Canc Ctr, Sapporo, Hokkaido, Japan
[5] KKR Sapporo Med Ctr, Sapporo, Hokkaido, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
18121
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Biweekly docetaxel and carboplatin as first-line therapy in patients with advanced non-small cell lung cancer (NSCLC). Finally results of a phase II study
    Firvida, J. L.
    Esquerdo, G.
    Amenedo, M.
    Salgado, M.
    LLorca, C.
    Perez, E.
    Cervera Grau, J.
    Ramos, M.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [2] PEMETREXED AND CARBOPLATIN VERSUS DOCETAXEL AND CARBOPLATIN AS FIRST-LINE TREATMENT FOR PATIENTS WITH ADVANCED, NON-SQUAMOUS, NON-SMALL CELL LUNG CANCER (NSCLC)
    Ganju, Vinod
    Pereira, Jose
    Kim, Joo-Hang
    Magallanes, Manuel
    Lee, Dae-Ho
    Wang, Jie
    Martinez, Luis
    Barraclough, Helen
    Van Kooten, Maximiliano
    Orlando, Mauro
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S417 - S418
  • [3] Docetaxel and carboplatin as first-line therapy in advanced non-small cell lung carcinoma: A phase II study
    Jahanzeb, M
    Sarna, G
    Hirsch, R
    Radice, P
    Koletsky, A
    Martinez, M
    Kruglyak, E
    Wolin, E
    Camacho, E
    Kronish, L
    Motl, S
    [J]. ANTICANCER RESEARCH, 2004, 24 (2C) : 1239 - 1242
  • [4] Phase I/II trial of docetaxel (D) and Carboplatin (CBDCA) as first-line chemotherapy in advanced non-small cell lung cancer (NSCLC)
    Giannakakis, T
    Papadouris, S
    Kourousis, C
    Kalbakis, NK
    Tzianni, V
    Lidaki, E
    Androulakis, N
    Souklakos, J
    Sarra, E
    Georgoulias, V
    [J]. ANNALS OF ONCOLOGY, 1998, 9 : 94 - 94
  • [5] Phase II trial of a combination of weekly docetaxel and four-weekly carboplatin in the first-line treatment of advanced non-small cell lung cancer (NSCLC)
    Ozguroglu, Mustafa
    Evrensel, Turkkan
    Er, Ozlem
    Turna, Hande
    Yanmaz, Teoman
    Yildiz, Ozcan
    Mandel, Nil
    Serdengecti, Suheyla
    [J]. ANNALS OF ONCOLOGY, 2006, 17 : 225 - 225
  • [6] Analysis of continuous first-line treatment with docetaxel and carboplatin for advanced non-small cell lung cancer
    Aoki, Takuya
    Ebihara, Akinori
    Yogo, Yurika
    Suemasu, Keiichi
    Sakamaki, Fumio
    [J]. ONCOLOGY LETTERS, 2014, 7 (06) : 1771 - 1777
  • [7] A Phase II Study of First-Line Chemotherapy with Weekly Carboplatin Plus Gemcitabine in Advanced Non-Small Cell Lung Cancer
    Mori, Kiyoshi
    Kamiyama, Yukari
    Kasai, Hisashi
    Kodama, Tetsuro
    [J]. CHEMOTHERAPY, 2012, 58 (01): : 78 - 83
  • [8] A study of weekly docetaxel and carboplatin as first-line chemotherapy for advanced non-small cell lung cancer
    Jiang, Haiping
    Zhang, Xiaochen
    Chen, Jing
    Zhang, Ling
    Xiong, Jianping
    Zhong, Lin
    Yu, Feng
    Qian, Jiong
    Yu, Lanfang
    Wang, Xiaoting
    Shi, Genming
    Deng, Jing
    Xu, Nong
    [J]. JOURNAL OF THORACIC DISEASE, 2014, 6 (02) : 79 - 85
  • [9] Phase II study of biweekly gemcitabine and docetaxel as first-line treatment for advanced disease in elderly non-small cell lung cancer (NSCLC) patients.
    Llorca, C.
    Esquerdo, G.
    Munoz, J., Sr.
    Sanchez-Hernandez, A.
    Gomez-Codina, J.
    Juan Vidal, O.
    Macia, S.
    Catot, S.
    Giner, V.
    Aparisi, F.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [10] Phase II study of biweekly carboplatin and paclitaxel as first-line treatment for elderly patients with advanced non-small cell lung cancer
    Terai, H.
    Soejima, K.
    Nakamura, M.
    Naoki, K.
    Yasuda, H.
    Satomi, R.
    Nakayama, S.
    Yoda, S.
    Ikemura, S.
    Sato, T.
    Asano, K.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
12345